Skip to content

Effect of Unani formulation in Shaqiqa Migraine without Aura

Clinical evaluation of therapeutic efficacy of Habb i Quqaya in the management of Shaqiqa (Migraine without Aura) A Randomized, Open Label, Standard Control Study - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108031
Enrollment
46
Registered
2026-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G430- Migraine without aura

Interventions

Intervention1: Habb (Tablet): It is a classsical Unani formulation taken from Al-Qarabadeen. The formulation comprises of 7 herbal drugs namely, Elwa (Aloe barbedensis) Afsanteen (Artemisia absenthium

Sponsors

Central Council for Research in Unani Medicine (CCRUM), New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Clinically diagnosed patient of Migraine without Aura according to ICHD-3 criteria. 2) Patients in age group of 18 to 65 years. 3) Irrespective of gender. 4) Patients, who are ready to sign the informed consent, follow the protocol and willing to participate in clinical study voluntarily 5) Willing to complete daily diary (as mentioned in objective parameter)

Exclusion criteria

Exclusion criteria: 1) Patient who fails to give written consent. 2) Patient with a known history of epilepsy and stroke. 3) Patients suffering from systemic illnesses such as uncontrolled diabetes mellitus, uncontrolled hypertension, malignancy, liver and kidney dysfunction. 4) Pregnant and lactating mother.

Design outcomes

Primary

MeasureTime frame
MIDAS (Migraine Disability Assessment scale)Timepoint: 45 days.

Secondary

MeasureTime frame
VAS (Visual Analog scale) Headache frequency (from daily headache diary )Timepoint: 45 days.

Countries

India

Contacts

Public ContactDr Ahtesham Ahamad

Regional Research Institute of Unani Medicine (RRIUM), Srinagar

drarsheediqbal@gmail.com7006019911

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026